IP Library Granted Patent US 9,649,115
Granted Patent B2
US 9,649,115 · App. 14/308,695 · Granted May 16, 2017

Medical device for modification of left atrial appendage and related systems and methods

Inventors: Daryl R. Edmiston (Draper, UT); Clark C. Davis (Holladay, UT); John Alexander Martin (Park City, UT); Scott D. Miles (Sandy, UT)
Assignee: Coherex Medical, Inc.
A61B17/12177A61B17/0057A61B17/12022A61B17/12122A61B17/12172A61F2/2427A61B2017/0069A61B2017/00575A61B2017/00597A61B2017/1205A61B2017/12054A61B2017/12095
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,649,115
App. No.
14/308,695
Granted
May 16, 2017
Kind
B2
Abstract

Devices, methods and systems are provided for occluding an opening within the tissue of a body, such as a left atrial appendage. In one embodiment, a medical device coupled to a delivery catheter includes a fluid flow path that facilitates contrast fluid to pass through the delivery catheter and the medical device to a distal side thereof to provide imaging information as to the position of the medical device positioned in the opening, such as the left atrial appendage. In another embodiment, a medical device is coupled to a delivery catheter, the medical device including flaps adjacent a hub of the medical device that close-off a bore of the hub upon the catheter being detached from the medical device.

Claims (17)

1. A method for modifying a left atrial appendage (“LAA”) of a heart, the method comprising:

positioning a medical device coupled to a distal end of a delivery catheter within the LAA of the heart such that the medical device includes an occluder portion having a substantially non-permeable material that substantially blocks fluid from exiting the LAA;

injecting contrast fluid through the delivery catheter and through a hub of the medical device and into the LAA;

viewing the contrast fluid injected into the LAA with an imaging device; and

determining whether the medical device is properly positioned in the LAA upon viewing the contrast fluid in the LAA with the non-permeable material of the medical device substantially maintaining the contrast fluid in the LAA;

wherein the positioning the medical device comprises deploying the occluder portion of the medical device and, then, upon the occluder portion being in an expanded, deployed position, actuating an anchor portion of the medical device from a retracted position to an anchor deployed position.

2. The method according to claim 1 , further comprising advancing the medical device through a sheath in the vasculature and to the LAA of the heart.

3. The method according to claim 1 , wherein the injecting comprises injecting the contrast fluid through a fluid port in a handle coupled to a proximal end of the delivery catheter such that the contrast fluid flows through a lumen defined within and along a longitudinal length of the delivery catheter.

4. The method according to claim 1 , wherein the positioning comprises engaging the anchor portion of the medical device to tissue in the LAA.

5. The method according to claim 1 , wherein the injecting contrast fluid comprises injecting contrast fluid with an injection member.

6. The method according to claim 1 , wherein the injecting comprises injecting the fluid along a flow path that is defined at least through the hub of the medical device such that the contrast fluid exits a distal side of the hub of the medical device and into the LAA.

7. The method according to claim 1 , wherein the determining comprises determining whether there are gaps between an outer periphery of the medical device and the tissue of the LAA by viewing the contrast fluid.

8. The method according to claim 1 , further comprising re-positioning the medical device in the LAA upon determining contrast fluid is not being substantially maintained within the LAA with the medical device.

9. The method according to claim 1 , wherein the positioning the medical device comprises actuating the anchor portion of the medical device between the retracted position and the anchor deployed position such that a portion of the anchor portion is moveable through the hub of the medical device.

10. The method according to claim 9 , wherein the actuating the anchor portion comprises pivoting the anchor portion at a hinged coupling between the anchor portion and the occluder portion.

11. The method according to claim 9 , wherein the actuating the anchor portion comprises actuating actuator arms of the anchor portion substantially along an axis of the medical device.

12. The method according to claim 1 , wherein the positioning the medical device comprises substantially occluding the LAA such that the non-permeable material of the occluder portion comprises ePTFE.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Dec 15, 2015
From: HEALTHCARE FINANCIAL SOLUTIONS, LLC, SUCCESSOR IN INTEREST TO GENERAL ELECTRIC CAPITAL CORPORATION
To: COHEREX MEDICAL, INC.
Reel/Frame 037294/0035 →
SECURITY INTEREST Recorded Aug 14, 2015
From: COHEREX MEDICAL, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 036332/0904 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2015
From: EDMISTON, DARYL R; DAVIS, CLARK C; MARTIN, JOHN ALEXANDER; MILES, SCOTT D
To: COHEREX MEDICAL, INC.
Reel/Frame 036021/0638 →
Continuity (11)
Continuation In Part 13666612 · Nov 1, 2012
Continuation In Part 12818046 · Jun 17, 2010
Provisional Application 61837628 · Jun 20, 2013
Provisional Application 61553948 · Nov 1, 2011
Provisional Application 61661799 · Jun 19, 2012
Provisional Application 61345514 · May 17, 2010
Provisional Application 61325230 · Apr 16, 2010
Provisional Application 61320635 · Apr 2, 2010
Provisional Application 61294058 · Jan 11, 2010
Provisional Application 61218018 · Jun 17, 2009
Related Publication 20140364941A1 · Dec 11, 2014